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The human gastrointestinal tract is occupied by a
complex and abundant microbial community reaching as
high as 1013–1014 microorganisms in the colon. This micro-
biota participates in a symbiotic relationship with their
eukaryotic host, and this partnership is viewed as essential
for maintaining homeostasis. The microbiome contains a
wealth of information, encompassing 150-fold as many
genes as the human genome and performing essential and
nonredundant tasks (e.g.,nutrition/energy balance, immune
system toning, and pathogen exclusion) for the host. Recent
studies have hinted that a core human microbiome exists at
the gene level, with a large number of microbial genes and
pathways shared among individuals. Deviations from this
core microbiome could potentially aﬀect human health and
promote disease state. The coexistence of the host with its
intestinal microbiota is tightly controlled at various levels
and an accumulating body of evidence suggests that the
failure of this homeostasis is an important contribution to
disease development. Recent discoveries clearly suggest that
the gut microbiota of individuals throughout their lifespan
is a powerful determinant of chronic diseases and that the
mechanisms underlying this link involve the development
of inﬂammatory activity. The microbiota has already been
linked to cardiac development, angiogenesis, innate and
adaptive immunity, metabolism, nutrient acquisition, and
gastrointestinal developmentandhomeostasis.Furthermore,
alterations in microbial community composition are asso-
ciated with multiple diseases, including obesity, fatty liver
disease, type 1 and type 2 diabetes, kidney disease, arthritis,
and inﬂammatory bowel diseases (IBD).
On the host side, a series of mechanisms help contain
the formidable antigenic power of the microbiota. One of
the main mechanisms, which could be regrouped under the
wide umbrella of functional mucosal barrier, includes the
formation of epithelial tight junction, mucus production,
antimicrobial peptide secretion, and immunoglobulin A
release. Equally important is the presence of a sophis-
ticated repertoire of innate receptors, each recognizing
speciﬁc conserved microbial patterns present on various
microorganisms. Because the basic structure of bacteria is
relatively conserved, eukaryotes have developed throughout
evolution sensing systems to detect these bacterial signatures
which includecell wall components, locomotion system, and
nucleic acids. These microbial sensors are termed pattern
recognition receptors (PRR-) and include retinoic acid
inducible gene-I-like RNA helicases (RLH), C-type lectin
receptors (CLR), nucleotide-binding domain leucine-rich
repeatproteins(NLR),alsoknownasNod-likereceptors,and
Toll-like receptors (TLR).This arsenal of innate sensors plays
a critical role in maintaining intestinal homeostasis through
elimination of pathogenic microorganisms and preventing
the formation of a dysbiotic microbiota. Interestingly, mod-
ulation of the gut microbiota and prevention of a dysbiotic
state have become the focus ofintense research. Indeed, vari-
ous strategies including the introduction of prebiotic, probi-
otic, dietary compounds, and recently fecal transplantation
to treat recurrent C. diﬃcile infection have received special
attention to treat various intestinal inﬂammatory disorders.
Clearly, one could appreciate the complexity of these
host-microbe interaction and the deleterious consequences2 International Journal of Inﬂammation
of an improper response to both the microbiota and
infectious microorganisms. For example, Nod2 polymorph-
isms causing a loss of bacterial recognition mechanisms
have been identiﬁed as susceptibility factors for Crohn’s
disease. Moreover, NOD2 variants are also implicated in the
developmentof gingivitis and Graft-versus-host disease after
bone marrow transplantation.
This special issue of the International Journal of Inﬂam-
mation brings into focus the complexity of bacteria-host
interactionsandtheimpact oftheseinteractionsonintestinal
homeostasis, and conversely in the development of various
pathological conditions.
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